Standard BioTools Inc. (LAB) KPIs and segments
Close on Nov 12, 2026Market cap $255.73MP/E 3.0Yield –
KPIs & segments
Operating metrics and segments that drive Standard BioTools's business
Standard BioTools's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product revenue($M) | 14.5 | 15.5 | 17.4 | 13.8 | 15.7 | 14.8 | 18.4 | 15.8 | 15.9 | 23.6 | 21.4 | 18.7 | |
Consumables($M) | 9.39 | 11.0 | 8.95 | 8.71 | 10.5 | 8.14 | 10.8 | 10.5 | 8.85 | 17.3 | 10.4 | 9.71 | |
Services and other revenue($M) | 5.59 | 5.69 | 6.39 | 5.75 | 6.09 | 5.44 | 6.34 | 6.31 | 6.60 | 6.80 | 6.66 | ||
Instruments($M) | 5.13 | 4.47 | 8.46 | 5.10 | 5.22 | 6.65 | 7.67 | 5.27 | 7.05 | 6.29 | 10.9 | 9.00 | |
Earlier reporting (last reported 2025)7 | |||||||||||||
EMEA($M) | 8.62 | 9.36 | 10.7 | 7.25 | 9.13 | 8.90 | 9.44 | 8.88 | 9.07 | 12.5 | 8.77 | 8.16 | |
Americas($M) | 7.65 | 7.75 | 6.96 | 7.84 | 8.69 | 7.07 | 10.0 | 9.76 | 9.17 | 24.7 | 13.2 | 10.9 | |
Asia-Pacific($M) | 3.84 | 4.04 | 6.11 | 4.47 | 3.95 | 4.26 | 5.30 | 3.45 | 4.26 | 8.36 | 6.20 | 6.34 | |
Earlier reporting (last reported 2023)1 | |||||||||||||
Product revenue($M) | 7.72 | 7.75 | 8.62 | 7.07 | 8.07 | 8.35 | 9.57 | 9.62 | 8.12 | 10.8 | 9.72 | 7.31 | |
Services and other revenue($M) | 2.82 | 3.56 | 2.76 | 2.41 | 2.56 | 2.70 | 1.79 | 2.51 | 2.25 | 3.64 | 3.85 | ||
Earlier reporting (last reported 2025)2 | |||||||||||||
Earlier reporting (last reported 2024)2 | |||||||||||||
Earlier reporting (last reported 2024)2 | |||||||||||||
Remaining performance obligations (RPO)($M) | 17.1 | 18.5 | 18.3 | 19.7 | 18.2 | 18.8 | 20.6 | 22.5 | 24.7 | ||||
28 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-05.
See a number that looks wrong?